Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human

References

• Animal Procedures Committee. 2002. The use of primates under the Animals (Scientific Procedures) Act (1986): analysis of current trends with particular reference to regulatory toxicology. London: Animal Procedures Committee Publications Centre.
   Google Scholar
• Campbell DB. 1994. Can allometric interspecies scaling be used to predict human kinetics? Drug Information Journal 28:235–245.
   Google Scholar
• Chiou WL, Buehler PW. 2002. Comparison of oral absorption and bioavailability of drugs between monkey and human. Pharmaceutical Research 19:868–874.
   PubMed Web of Science ®Google Scholar
• Chiou WL, Jeong HY, Chung SM, Wu TC. 2000. Evaluation of using dog as an animal model to study the fraction of oral dose absorbed of 43 drugs in humans. Pharmaceutical Research 17:135–140.
   PubMed Web of Science ®Google Scholar
• Clark DE. 1999. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. I. Prediction of intestinal absorption. Journal of Pharmaceutical Sciences 88: 807–814.
   PubMed Web of Science ®Google Scholar
• Dorato MA, Vodicnik MJ. 1994. The toxicologic assessment of pharmaceutical and biotechnology products. In: Hayes AW, editor. Principles and methods of toxicology. New York: Raven. p. 189–219.
   Google Scholar
• Feng MR, Lou X, Brown RR, Hutchaleelaha A. 2000. Allometric pharmacokinetic scaling: towards the prediction of human oral phrmacokinetics. Pharmaceutical Research 17:410–418.
   PubMed Web of Science ®Google Scholar
• Ings RM. J. 1990. Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20, 1201–1231.
   PubMed Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23:3–25.
   Web of Science ®Google Scholar
• Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews 23:3–25.
   Web of Science ®Google Scholar
• Mahmood I. 2000. Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods. Drug Metabolism and Drug Interactions 16:143–155.
   PubMedGoogle Scholar
• Mahmood I. 2000. Can absolute oral bioavailability in humans be predicted from animals? A comparison of allometry and different indirect methods. Drug Metabolism and Drug Interactions 16:143–155.
   PubMedGoogle Scholar
• Nagilla R, Ward KW. 2004. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. Journal of Pharmaceutical Sciences 93:2522–2534.
   PubMed Web of Science ®Google Scholar
• Nagilla R, Ward KW. 2004. A comprehensive analysis of the role of correction factors in the allometric predictivity of clearance from rat, dog, and monkey to humans. Journal of Pharmaceutical Sciences 93:2522–2534.
   PubMed Web of Science ®Google Scholar
• Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. 1997. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Journal of Pharmacology and Experimental Therapeutics 283:46–58.
   PubMed Web of Science ®Google Scholar
• Obach RS, Baxter JG, Liston TE, Silber BM, Jones BC, MacIntyre F, Rance DJ, Wastall P. 1997. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. Journal of Pharmacology and Experimental Therapeutics 283:46–58.
   PubMed Web of Science ®Google Scholar
• Palm K, Luthman K, Ungell AL, Strandlund G, Artursson P. 1996. Correlation of drug absorption with molecular surface properties. Journal of Pharmaceutical Sciences 85:32–39.
   PubMed Web of Science ®Google Scholar
• Palm K, Stenberg P, Luthman K, Artursson P. 1997. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharmaceutical Research 14:568–571.
   PubMed Web of Science ®Google Scholar
• Palm K, Luthman K, Ungell AL, Strandlund G, Artursson P. 1996. Correlation of drug absorption with molecular surface properties. Journal of Pharmaceutical Sciences 85:32–39.
   PubMed Web of Science ®Google Scholar
• Palm K, Stenberg P, Luthman K, Artursson P. 1997. Polar molecular surface properties predict the intestinal absorption of drugs in humans. Pharmaceutical Research 14:568–571.
   PubMed Web of Science ®Google Scholar
• Poggesi I. 2004. Predicting human pharmacokinetics from preclinical data. Current Opinion in Drug Discovery and Development 7:100–111.
   PubMed Web of Science ®Google Scholar
• Poggesi I. 2004. Predicting human pharmacokinetics from preclinical data. Current Opinion in Drug Discovery and Development 7:100–111.
   PubMed Web of Science ®Google Scholar
• Roberts SA. 2003. Drug metabolism and pharmacokinetics in drug discovery. Current Opinion in Drug Discovery and Development 6:66–80.
   Google Scholar
• Roberts SA. 2003. Drug metabolism and pharmacokinetics in drug discovery. Current Opinion in Drug Discovery and Development 6:66–80.
   Google Scholar
• Turner JV, Glass BD, Agatonovic-Kustrin S. 2003. Prediction of drug bioavailability based on molecular structure. Analytica Chimica Acta 485:89–102.
   Web of Science ®Google Scholar
• Turner JV, Glass BD, Agatonovic-Kustrin S. 2003. Prediction of drug bioavailability based on molecular structure. Analytica Chimica Acta 485:89–102.
   Web of Science ®Google Scholar
• Veber DF, Johnson SR, Cheng, H-Y, Smith BR, Ward KW, Kopple KD. 2002. Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry 45:2615–2623.
   PubMed Web of Science ®Google Scholar
• Wajima T, Fukumura K, Yano Y, Oguma T. 2003. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance. Journal of Pharmaceutical Sciences 92:2427–2440.
   PubMed Web of Science ®Google Scholar
• Wajima T, Fukumura K, Yano Y, Oguma T. 2003. Prediction of human pharmacokinetics from animal data and molecular structural parameters using multivariate regression analysis: Oral clearance. Journal of Pharmaceutical Sciences 92:2427–2440.
   PubMed Web of Science ®Google Scholar
• Ward KW, Smith BR. 2004a. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. I. Clearance. Drug Metabolism and Disposition 32:603–611.
   PubMed Web of Science ®Google Scholar
• Ward KW, Smith BR. 2004b. A comprehensive quantitative and qualitative evaluation of extrapolation of intravenous pharmacokinetic parameters from rat, dog, and monkey to humans. H. Volume of distribution and mean residence time. Drug Metabolism and Disposition 32:612–619.
   PubMed Web of Science ®Google Scholar
• Weidekamm E, Portmann R, Suter K, Partos C, Dell D, Lücker PW. 1987. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans. Antimicrobial Agents and Chemotherapy 31:1909–1914.
   Google Scholar
• Wiseman EH, Chiaini J. 1972. Anti-inflammatory and pharmacokinetic properties of sudoxicam N-(2-thiazoly1)-4-hydroxy-2-methyl-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide. Biochemical Pharmacology 21: 2323–2334.
   PubMed Web of Science ®Google Scholar
• Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherborne B, Cooper I, Platts JA. 2001. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure—activity relationship (QSAR) with the Abraham descriptors. Journal of Pharmaceutical Sciences 90:749–784.
   PubMed Web of Science ®Google Scholar
• Zhao YH, Le J, Abraham MH, Hersey A, Eddershaw PJ, Luscombe CN, Boutina D, Beck G, Sherborne B, Cooper I, Plans JA. 2001. Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure—activity relationship (QSAR) with the Abraham descriptors. Journal of Pharmaceutical Sciences 90:749–784.
   PubMed Web of Science ®Google Scholar